Skip to main content
. 2020 Aug 11;112(5):1188–1199. doi: 10.1093/ajcn/nqaa203

TABLE 4.

Outcome levels at the end of the 8-wk phases1

Outcome Plant, mean ± SEM Animal, mean ± SEM Plant–Animal difference, mean (95% CI) P value2
Primary
 TMAO,3 µM 2.7 ± 0.3 4.7 ± 0.9 −2.0 (−3.6, −0.3) 0.012
Secondary
 IGF-1, ng/mL 147.6 ± 7.5 152.3 ± 8.3 −4.7 (−13.9, 4.5) 0.30
 Weight, kg 78.7 ± 3.0 79.6 ± 3.0 −1.0 (−1.5, −0.5) <0.001
 Insulin, µIU/mL 9.2 ± 1.1 8.8 ± 0.9 0.4 (−0.7, 1.5) 0.38
 Glucose, mg/dL 94.9 ± 1.6 94.5 ± 1.4 0.5 (−1.8, 2.8) 0.65
 Lipids, mg/dL
  LDL-C 109.9 ± 4.5 120.7 ± 4.5 −10.8 (−17.3, −4.3) 0.002
  HDL-C 62.5 ± 2.2 61.8 ± 2.5 0.7 (−2.4, 3.8) 0.66
  Triglycerides 99.7 ± 7.3 100.2 ± 7.0 −0.6 (−10.5, 9.2) 0.89
 Blood pressure, mm Hg
  Systolic 114.5 ± 2.1 113.1 ± 1.9 1.2 (−1.4, 4.1) 0.31
  Diastolic 70.0 ± 1.4 68.8 ± 1.2 1.1 (−0.8, 3.2) 0.20
1

n = 36. Animal, animal meat; HDL-C, HDL cholesterol; IGF-1, insulin-like growth factor 1; LDL-C, LDL cholesterol; Plant, plant-based alternative meat; TMAO, trimethylamine-N-oxide.

2

Likelihood ratio test from mixed-effects model evaluating change from baseline for each product type (Plant compared with Animal), adjusting for order and phase.

3

Significant order effect in model (P = 0.023).